Cervical clear cell adenocarcinoma

MONDO:0006135

A rare morphologic variant of cervical adenocarcinoma composed of clear and hobnail cells. It is associated with in utero exposure to diethylstilbestrol (DES).

Also known as: cervical clear cell adenocarcinoma, cervical clear cell carcinoma, cervix clear cell adenocarcinoma, cervix clear cell carcinoma, cervix uteri clear cell adenocarcinoma, cervix uteri clear cell carcinoma, clear cell adenocarcinoma of cervix, clear cell adenocarcinoma of cervix uteri

2855 clinical trials for this condition and its sub-types, 4 tagged with Cervical clear cell adenocarcinoma itself.

Follow this condition to get notified about new trials

Where it sits in the disease tree

Browse by category →

Part of

↑ Clear cell adenocarcinoma (201) ↑ Cervical adenocarcinoma (34)

Sub-types of Cervical clear cell adenocarcinoma

Uterine ligament clear cell adenocarcinoma 0 trials

Including sub-types (2855) Tagged with Cervical clear cell adenocarcinoma (4)

Trials to join now! 3 Not yet finished but already full! 1

Immunotherapy duo takes on rare tumors

Disease control Ongoing

This phase 2 trial is testing a combination of two immunotherapy drugs, nivolumab and ipilimumab, in 798 people with over 50 types of rare cancers. The goal is to see if these drugs can shrink tumors by helping the immune system attack cancer cells. Participants receive the drugs…

Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Jun 27, 2026 14:00 UTC

Cervical clear cell adenocarcinoma

Where it sits in the disease tree

Immunotherapy duo takes on rare tumors